Skandinaviska Enskilda Banken (SEB)’s Legend Biotech LEGN Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,100	Closed	-$101K	–	772
2025 Q3	$101K	Hold	3,100	–	–	﹤0.01%	739
2025 Q2	$110K	Hold	3,100	–	–	﹤0.01%	780
2025 Q1	$105K	Hold	3,100	–	–	﹤0.01%	763
2024 Q4	$102K	Sell	3,100 -9,200	-75%	-$381K	﹤0.01%	773
2024 Q3	$599K	Hold	12,300	–	–	﹤0.01%	707
2024 Q2	$545K	Buy	12,300 +1,300	+12%	+$60K	﹤0.01%	685
2024 Q1	$617K	Buy	11,000 +100	+0.9%	+$6.03K	﹤0.01%	695
2023 Q4	$657K	Buy	10,900 +3,200	+42%	+$203K	﹤0.01%	748
2023 Q3	$517K	Hold	7,700	–	–	﹤0.01%	766
2023 Q2	$532K	Hold	7,700	–	–	﹤0.01%	783
2023 Q1	$372K	Hold	7,700	–	–	﹤0.01%	794
2022 Q4	$384K	Buy	+7,700	New	+$373K	﹤0.01%	751

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s LEGN Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Legend Biotech (LEGN) in Q4 2025, closing a stake of 3,100 shares — an estimated $101K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in LEGN in Q4 2022 and held it in 12 quarters. The position peaked at $657K in Q4 2023. 200 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

Skandinaviska Enskilda Banken (SEB) reported no remaining Legend Biotech position as of Q4 2025 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 3,100 Legend Biotech shares in Q4 2025, an estimated $101K.
Skandinaviska Enskilda Banken (SEB) first reported a position in Legend Biotech in Q4 2022 and held it in 12 quarters.
Skandinaviska Enskilda Banken (SEB)'s Legend Biotech position peaked at $657K in Q4 2023.
200 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.